miR-619-5p and cardiogenic shock in patients with ST-segment elevation myocardial infarction

Rafael Escate, Teresa Padró, Rosa Suades, Jordi Sans-Roselló, Yvan Devaux, Päivi Lakkisto, Veli Pekka Harjola, Alessandro Sionis, Lina Badimon*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review


Background: Cardiogenic shock (CS) is a severe myocardial dysfunction secondary to various cardiac conditions including ST-segment elevation acute myocardial infarction (STEMI) and associated with a high risk of death. Little is known on epigenetic determinants in CS. Here, we investigated plasma miRNAs in relation to CS stratification in STEMI-patients. Methods: STEMI-patients (n = 49), with (CS, n = 25) and without CS (non-CS, n = 24) fulfilling inclusion criteria were included from HSCSP-cohort (Derivation-cohort). CS-miRNAs were analysed by Affymetrix-microarray and RT-PCR. Results were validated in a second cohort of CS-patients (CardShock: n = 35) with similar inclusion/exclusion criteria as the derivation cohort. In silico analysis were performed to identify potential miRNA target genes. Results: Of the 5-miRNA signature obtained from microarray analysis, miR-619-5p showed higher levels in CS than in Non-CS patients (p =.003) and discriminating power for CS by ROC (AUC:.752, p =.003). miR-619-5p directly associated with risk scores [GRACE, p =.001; CardShock, p <.001]. Furthermore, miR-619-5p showed discrimination power for death in CS. Thus, miRNA levels were significantly higher in patients with mortality outcome both in the Derivation HSCSP-cohort (p =.02; AUC:.78 ±.095) and the Validation CardShock-cohort (p =.017; AUC:.737 ±.086) By in silico analysis, miR-619-5p target genes and TNF-alpha were involved in the regulation of inflammation. miR-619-5p and TNF-alpha levels discriminated mortality outcome in CS-patients during 30-day follow-up (Validation-Cohort: ROC:.812, p =.002; HR: 9.99, p =.003). Conclusions: Up-regulation of miR-619-5p is found in the plasma of STEMI-patients with CS and mortality outcome. These findings highlight the specificity of epigenetic regulation of inflammation on the disease severity of MI.

Original languageEnglish
Article numbere14186
JournalEuropean Journal of Clinical Investigation
Early online date20 Feb 2024
Publication statusE-pub ahead of print - 20 Feb 2024


  • cardiovascular disease
  • epigenetic
  • inflammatory response
  • mortality risk
  • plasma miRNAs


Dive into the research topics of 'miR-619-5p and cardiogenic shock in patients with ST-segment elevation myocardial infarction'. Together they form a unique fingerprint.

Cite this